PlainRecalls
FDA Drug Moderate Class II Terminated

Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.

Reported: December 24, 2014 Initiated: November 26, 2014 #D-0299-2015

Product Description

Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.

Reason for Recall

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Details

Units Affected
58,920 bottles
Distribution
Nationwide and Puerto Rico
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 58,920 bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 24, 2014. Severity: Moderate. Recall number: D-0299-2015.